Internal Medicine, Hematology & Oncology · Baldwin Park, CA
NPI
1295883221
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1011 Baldwin Park Blvd
Baldwin Park, CA, 91706
Phone (626) 851-1011
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,861
536 services
Medicare patients, 2024
14
Average age 70
Drug cost, 2024
$2.6M
789 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Aswini Padmanabhan prescribed most often to Medicare patients was Anastrozole, with 199 prescriptions and refills. In total Aswini Padmanabhan wrote 789 Medicare prescriptions that cost $2.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 199 | 597 | 64 | $5,611 |
| Prednisone Generic | 50 | 51 | 14 | $371 |
| Ondansetron Hcl Generic | 49 | 50 | 28 | $403 |
| Hydroxyurea Generic | 33 | 76 | Under 11 | $1,585 |
| Dexamethasone Generic | 27 | 37 | 11 | $391 |
| Lenalidomide Generic | 27 | 27 | Under 11 | $380K |
| Brukinsa Zanubrutinib | 27 | 27 | Under 11 | $270K |
| Ibrance Palbociclib | 26 | 26 | Under 11 | $404K |
| Nivestym Filgrastim-Aafi | 25 | 25 | Under 11 | $17K |
| Abiraterone Acetate Generic | 25 | 25 | Under 11 | $3,135 |
| Tagrisso Osimertinib Mesylate | 23 | 23 | Under 11 | $396K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 16 | 16 | 11 | $282 |
| Xarelto Rivaroxaban | 13 | 15 | Under 11 | $7,085 |
| Rozlytrek Entrectinib | 12 | 12 | Under 11 | $167K |
| Posaconazole Generic | 12 | 12 | Under 11 | $2,169 |
Brand drugs: 202 claims; generic drugs: 587 claims; opioid claims: 20.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Aswini Padmanabhan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.